Mave Health Raises $2.1 Million to Globalize Neurotechnology-Based Mental Wellness
What is the news?
Mave Health, a pioneering neurotechnology company headquartered in Bengaluru and San Francisco, has successfully closed a $2.1 million seed funding round. Led by Blume Ventures, the round included participation from Inuka Capital, Stanford Angels, and several high-profile angel investors. Founded in 2023 by Dhawal Jain, Jai Sharma, and Aman Kumar, Mave Health is at the forefront of the “Global Indian Alpha” narrative, leveraging world-class engineering and research to build a consumer-friendly wearable for the global market.
Why is it interesting?
The company’s flagship product is a non-invasive headset that utilizes transcranial direct current stimulation (tDCS) to help users manage stress and improve focus. By targeting the prefrontal cortex with low-intensity electrical pulses, the device offers a drug-free alternative for cognitive enhancement and emotional regulation. Mave Health plans to use the new funding to scale its manufacturing capabilities and officially launch its product in the United States and India by April 2026.
With early beta data showing that 75% of users experienced stress reduction within just four weeks, Mave Health is positioning India as a hub for deep-tech innovation in the healthcare sector. This investment marks a significant milestone in the startup’s journey to make sophisticated brain-health tools as accessible as fitness trackers for a global audience.
Read more: Neurotechnology startup Mave Health secures $2.1 Mn led by Blume Ventures – Entrackr